Verisante Technology Inc. (VRSEF)
USD 0.01
(93.33%)
USD 0.01
(93.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 26.4 Thousand CAD | -81.01% |
| 2015 | 139 Thousand CAD | -36.47% |
| 2014 | 218.81 Thousand CAD | -71.78% |
| 2013 | 775.3 Thousand CAD | 0.0% |
| 2012 | - CAD | -100.0% |
| 2011 | 2249.00 CAD | -80.29% |
| 2010 | 11.4 Thousand CAD | -62.54% |
| 2009 | 30.45 Thousand CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - CAD | 0.0% |
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 FY | - CAD | 0.0% |
| 2023 Q4 | - CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2016 Q4 | - CAD | -100.0% |
| 2016 FY | 26.4 Thousand CAD | -81.01% |
| 2016 Q3 | 3000.00 CAD | -60.0% |
| 2016 Q1 | 15.9 Thousand CAD | 1573.68% |
| 2016 Q2 | 7500.00 CAD | -52.83% |
| 2015 Q2 | 76.17 Thousand CAD | 0.0% |
| 2015 Q4 | 950.00 CAD | -98.46% |
| 2015 FY | 139 Thousand CAD | -36.47% |
| 2015 Q1 | - CAD | -100.0% |
| 2015 Q3 | 61.88 Thousand CAD | -18.77% |
| 2014 Q2 | 112.8 Thousand CAD | 182.0% |
| 2014 FY | 218.81 Thousand CAD | -71.78% |
| 2014 Q1 | 40 Thousand CAD | 151.28% |
| 2014 Q4 | 66.01 Thousand CAD | 0.0% |
| 2014 Q3 | - CAD | -100.0% |
| 2013 Q1 | 235 Thousand CAD | 0.0% |
| 2013 Q3 | 440.3 Thousand CAD | 147.36% |
| 2013 FY | 775.3 Thousand CAD | 0.0% |
| 2013 Q4 | -78 Thousand CAD | -117.72% |
| 2013 Q2 | 178 Thousand CAD | -24.26% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | -100.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 FY | - CAD | -100.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | 2249.00 CAD | -80.29% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | 2249.00 CAD | 0.0% |
| 2010 Q2 | 6454.00 CAD | 30.25% |
| 2010 Q1 | 4955.00 CAD | -81.47% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | 11.4 Thousand CAD | -62.54% |
| 2010 Q3 | - CAD | -100.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 FY | 30.45 Thousand CAD | 0.0% |
| 2009 Q4 | 26.74 Thousand CAD | 1098.25% |
| 2009 Q3 | 2232.00 CAD | 50.61% |
| 2009 Q2 | 1482.00 CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | 100.0% |
| ALR Technologies Inc. | 7468.00 USD | 100.0% |
| Aurora Spine Corporation | 14.52 Million USD | 100.0% |
| AVITA Medical, Inc. | 50.56 Million USD | 100.0% |
| Avitar, Inc. | 3.1 Million USD | 100.0% |
| BioElectronics Corporation | 714.7 Thousand USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| Broncus Holding Corporation | 10.25 Million USD | 100.0% |
| Brain Scientific Inc. | 214.56 Thousand USD | 100.0% |
| BrainsWay Ltd. | 31.78 Million USD | 100.0% |
| Capital Group Holdings, Inc. | - USD | NaN% |
| Health Logic Interactive Inc. | - USD | NaN% |
| CVR Medical Corp. | - USD | NaN% |
| NIOX Group Plc | 46.84 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | - USD | NaN% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | 100.0% |
| Electromedical Technologies, Inc. | 1.34 Million USD | 100.0% |
| Escalon Medical Corp. | 11.98 Million USD | 100.0% |
| Lombard Medical, Inc. | 12.16 Million USD | 100.0% |
| Fuse Medical, Inc. | 16.11 Million USD | 100.0% |
| Guided Therapeutics, Inc. | 98 Thousand USD | 100.0% |
| Heart Tronics, Inc. | - USD | NaN% |
| Hamilton Thorne Ltd. | 68.45 Million USD | 100.0% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | 100.0% |
| IR-Med Inc. | - USD | NaN% |
| Kelyniam Global, Inc. | 2.67 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| MicroPort Scientific Corporation | 950.72 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | - USD | NaN% |
| Medical Supply International USA, Inc. | 2.81 Million USD | 100.0% |
| Nanomix Corporation | 15.45 Thousand USD | 100.0% |
| Nu-Med Plus, Inc. | - USD | NaN% |
| NewCardio, Inc. | 257.39 Thousand USD | 100.0% |
| Nexeon MedSystems Inc. | 3.3 Million USD | 100.0% |
| Odyssey Group International, Inc. | - USD | NaN% |
| Össur hf. | 785.68 Million USD | 100.0% |
| Össur hf. | 785.68 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 1.97 Million USD | 100.0% |
| Polarean Imaging plc | 890.93 Thousand USD | 100.0% |
| Positron Corporation | 734.66 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | 100.0% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | 100.0% |
| Vivos Inc. | 19.5 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | NaN% |
| Smith & Nephew plc | 5.68 Billion USD | 100.0% |
| SANUWAVE Health, Inc. | 20.39 Million USD | 100.0% |
| SS Innovations International, Inc. | 5.87 Million USD | 100.0% |
| Stratec SE | 289.14 Million USD | 100.0% |
| Theraclion SA | 1.82 Million USD | 100.0% |
| United American Healthcare Corporation | - USD | NaN% |
| Urologix, Inc. | 14.23 Million USD | 100.0% |
| QHSLab, Inc. | 1.4 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| VMS Rehab Systems, Inc. | 71.70 USD | 100.0% |
| Vycor Medical, Inc. | 1.46 Million USD | 100.0% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | 100.0% |
| Wellstar International, Inc. | - USD | NaN% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | 100.0% |